A phase I-II evaluation of veliparib (NSC #737664), topotecan, and filgrastim or pegfilgrastim in the treatment of persistent or recurrent carcinoma of the uterine cervix: an NRG Oncology/Gynecologic Oncology Group study

A phase I-II evaluation of veliparib (NSC #737664), topotecan, and filgrastim or pegfilgrastim in the treatment of persistent or recurrent carcinoma of the uterine cervix: an NRG Oncology/Gynecologic Oncology Group study

Item
http://www.wikidata.org/entity/Q33419816

A phase I-II evaluation of veliparib (NSC #737664), topotecan, and filgrastim or pegfilgrastim in the treatment of persistent or recurrent carcinoma of the uterine cervix: an NRG Oncology/Gynecologic Oncology Group study

Item
http://www.wikidata.org/entity/Q33419816
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
A phase I-II evaluation of vel ...... necologic Oncology Group study
@ast
A phase I-II evaluation of vel ...... necologic Oncology Group study
@en
type
label
A phase I-II evaluation of vel ...... necologic Oncology Group study
@ast
A phase I-II evaluation of vel ...... necologic Oncology Group study
@en
prefLabel
A phase I-II evaluation of vel ...... necologic Oncology Group study
@ast
A phase I-II evaluation of vel ...... necologic Oncology Group study
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P932
P356
P1433
P1476
A phase I-II evaluation of vel ...... necologic Oncology Group study
@en
P2093
P2860
P304
P31
P356
10.1097/IGC.0000000000000380
P433
P478
P577
P698
P932